Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Magnetic resonance imaging and neuropsychological findings in human immunodeficiency virus infection.

Levin HS, Williams DH, Borucki MJ, Hillman GR, Williams JB, Guinto FC Jr, Amparo EG, Crow WN, Pollard RB.

J Acquir Immune Defic Syndr. 1990;3(8):757-62.

PMID:
2366146
2.

Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group.

Stout JC, Ellis RJ, Jernigan TL, Archibald SL, Abramson I, Wolfson T, McCutchan JA, Wallace MR, Atkinson JH, Grant I.

Arch Neurol. 1998 Feb;55(2):161-8.

3.

Cognitive performance and regional brain volume in human immunodeficiency virus type 1 infection.

Kieburtz K, Ketonen L, Cox C, Grossman H, Holloway R, Booth H, Hickey C, Feigin A, Caine ED.

Arch Neurol. 1996 Feb;53(2):155-8.

PMID:
8639065
4.

Plasma levels of soluble CD14 and tumor necrosis factor-alpha type II receptor correlate with cognitive dysfunction during human immunodeficiency virus type 1 infection.

Ryan LA, Zheng J, Brester M, Bohac D, Hahn F, Anderson J, Ratanasuwan W, Gendelman HE, Swindells S.

J Infect Dis. 2001 Sep 15;184(6):699-706. Epub 2001 Aug 15.

PMID:
11517430
5.

Effects of human immunodeficiency virus and immune status on magnetic resonance imaging of the brain in hemophilic subjects: results from the hemophilia growth and development study.

Mitchell WG, Nelson MD, Contant CF, Bale JF Jr, Wilson DA, Bohan TP, Fenstermacher MJ.

Pediatrics. 1993 Apr;91(4):742-6.

PMID:
8096634
6.

Cognitive performance in HIV-1 infection: relationship to severity of disease and brain atrophy.

Poutiainen E, Elovaara I, Raininko R, Hokkanen L, Valle SL, Lähdevirta J, Iivanainen M.

Acta Neurol Scand. 1993 Feb;87(2):88-94.

PMID:
8442401
7.

The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center.

Heaton RK, Grant I, Butters N, White DA, Kirson D, Atkinson JH, McCutchan JA, Taylor MJ, Kelly MD, Ellis RJ, et al.

J Int Neuropsychol Soc. 1995 May;1(3):231-51.

PMID:
9375218
8.

Magnetic resonance imaging findings in HIV cognitive impairment.

Kieburtz KD, Ketonen L, Zettelmaier AE, Kido D, Caine ED, Simon JH.

Arch Neurol. 1990 Jun;47(6):643-5.

PMID:
2346391
9.

Cognition in early human immunodeficiency virus infection.

Wilkie FL, Eisdorfer C, Morgan R, Loewenstein DA, Szapocznik J.

Arch Neurol. 1990 Apr;47(4):433-40.

PMID:
2322137
10.

Neuropsychological performance in HIV-1-infected homosexual men: The Multicenter AIDS Cohort Study (MACS)

Miller EN, Selnes OA, McArthur JC, Satz P, Becker JT, Cohen BA, Sheridan K, Machado AM, Van Gorp WG, Visscher B.

Neurology. 1990 Feb;40(2):197-203.

PMID:
2405289
11.

Cerebral magnetic resonance relaxometry in HIV infection.

Wilkinson ID, Paley MN, Hall-Craggs MA, Chinn RJ, Chong WK, Sweeney BJ, Kendall BE, Miller RF, Newman SP, Harrison MJ.

Magn Reson Imaging. 1996;14(4):365-72.

PMID:
8782174
12.

Evidence of CNS impairment in HIV infection: clinical, neuropsychological, EEG, and MRI/MRS study.

Harrison MJ, Newman SP, Hall-Craggs MA, Fowler CJ, Miller R, Kendall BE, Paley M, Wilkinson I, Sweeney B, Lunn S, Carter S, Williams I.

J Neurol Neurosurg Psychiatry. 1998 Sep;65(3):301-7.

13.

Neuropsychological performance in symptomatic and asymptomatic HIV infection.

Bornstein RA, Nasrallah HA, Para MF, Whitacre CC, Rosenberger P, Fass RJ.

AIDS. 1993 Apr;7(4):519-24.

PMID:
8507418
14.

Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients.

Meyerhoff DJ, Bloomer C, Cardenas V, Norman D, Weiner MW, Fein G.

Neurology. 1999 Mar 23;52(5):995-1003.

PMID:
10102419
15.

Quantitative detection of brain aberrations in human immunodeficiency virus type 1-infected individuals by magnetic resonance imaging.

Sönnerborg A, Sääf J, Alexius B, Strannegård O, Wahlund LO, Wetterberg L.

J Infect Dis. 1990 Dec;162(6):1245-51.

PMID:
2230257
16.

Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. The HNRC Group.

Jernigan TL, Archibald S, Hesselink JR, Atkinson JH, Velin RA, McCutchan JA, Chandler J, Grant I.

Arch Neurol. 1993 Mar;50(3):250-5.

17.

Magnetic resonance abnormalities in HIV infection: a study in the drug-user risk group.

Handelsman L, Song IS, Losonczy M, Park S, Jacobson J, Wiener J, Aronson M.

Psychiatry Res. 1993 May;47(2):175-86.

PMID:
8341770
18.

[A magnetic tomography study: 3 out of 4 HIV-I infected men suffer subcortical pathologic changes].

Alexius B, Engelbrektsson K, Sääf J, Svedberg E, Wetterberg L, Sönnerborg A.

Lakartidningen. 1989 May 31;86(22):2108-11. Swedish.

PMID:
2733528
19.

Central nervous system involvement in human immunodeficiency virus disease. A prospective study including neurological examination, computerized tomography, and magnetic resonance imaging.

Pedersen C, Thomsen C, Arlien-Søborg P, Praestholm J, Kjaer L, Boesen F, Hansen HS, Nielsen JO.

Dan Med Bull. 1991 Aug;38(4):374-9.

PMID:
1914536
20.

A prospective controlled study of magnetic resonance imaging of the brain in gay men and parenteral drug users with human immunodeficiency virus infection.

Dooneief G, Bello J, Todak G, Mun IK, Marder K, Malouf R, Gorman J, Hilal S, Stern Y, Mayeux R.

Arch Neurol. 1992 Jan;49(1):38-43.

PMID:
1728262

Supplemental Content

Support Center